According to the clinical research, the new drugs for treating nephrotic syndrome mainly include tacrolimus, mycophenolate mofetil, rituximab and so on.
1. Tacrolimus: a new type of inhibitor, which can inhibit intracellular phosphatase activity and inhibit T-lymphocyte activation, so as to treat and relieve nephrotic syndrome.
2. Mycophenolate mofetil: a new type of immune agent that can inhibit lymphocytes to a certain extent, thus relieving the symptoms of the disease.
3. Rituximab: it can reduce the number of B cells, reduce the production of circulating antibodies, and reduce the damage of glomerular filtration barrier to play a therapeutic effect.
Nephrotic syndrome is a group of clinical syndromes, which can be caused by genetic, immune system abnormality and other factors, the main symptoms can be seen in large amount of proteinuria, hypoproteinemia, edema, hypertension and so on. Clinical treatment includes general treatment, drug treatment and so on.
If patients find nephrotic syndrome, it is recommended to go to the regular hospital in time, under the guidance of the doctor to give targeted treatment or treatment, do not self-medication.